Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Merck
Cipla
Argus Health
McKesson
Chubb
Federal Trade Commission
Deloitte
US Department of Justice

Generated: July 17, 2018

DrugPatentWatch Database Preview

Eszopiclone - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for eszopiclone and what is the scope of eszopiclone freedom to operate?

Eszopiclone
is the generic ingredient in two branded drugs marketed by Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Glenmark Generics, Lupin Ltd, Macleods Pharms Ltd, Mylan Pharms Inc, Orchid Hlthcare, Sun Pharma Global, Teva, West-ward Pharms Int, Wockhardt Ltd, and Sunovion Pharms Inc, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for eszopiclone. Thirty-four suppliers are listed for this compound.
Medical Subject Heading (MeSH) Categories for eszopiclone
Synonyms for eszopiclone
( )-Zopiclone
(+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate
(+)-(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl-4-methylpiperazine-1-carboxylate
(+)-Zopiclone
(5S)-6-(5-CHLOROPYRID-2-YL)-5-(4-METHYLPIPERAZIN-1-YL)CARBONYLOXY-7-OXO-6,7-DIHYDRO-5H-PYRROLO[3,4-B]PYRAZINE
(5S)-6-(5-chloropyridin-2-yl)-7-oxo-5H,6H,7H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate
(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate
(5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate
(plus)-Zopiclone
(S)-4-Methylpiperazine-1-carboxylic acid 6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl ester
(S)-6-(5-Chloro-2-pyridinyl)- 7-oxo- 6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5-yl- 4-methyl- 1-piperazinecarboxylate
(S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate
(S)-Zopiclone
[(7S)-6-(5-chloranylpyridin-2-yl)-5-oxidanylidene-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate
[(7S)-6-(5-chloro-2-pyridyl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate
[(7S)-6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate
1-Piperazinecarboxylic acid, 4-methyl-, (5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo(3,4-b)pyrazin-5-yl ester
1-Piperazinecarobxylic acid,4-methyl-,(5S)-6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester
138729-47-2
4-methyl-1-piperazinecarboxylic acid [(7S)-6-(5-chloro-2-pyridinyl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] ester
4CA-0512
729E472
A807426
AB00828423_06
AC-5546
AC-5547
AC1LJ6QN
AC1Q3ZTD
AK326230
AKOS015895596
AN-10908
API0024379
CAS-138729-47-2
CCG-213172
CHEBI:53760
CHEMBL1522
CPD000550478
CTK6I2909
D02624
D06ZII
DB00402
DEA No. 2784
DSSTox_CID_26086
DSSTox_GSID_46086
DSSTox_RID_81327
DTXSID8046086
EN300-52506
Esopiclone
Estorra
Estorra (TN)
Eszopiclone (JAN/USAN/INN)
Eszopiclone [USAN:INN]
FT-0658721
GBBSUAFBMRNDJC-INIZCTEOSA-N
GTPL7429
HE016880
HE309116
HMS2864O09
HMS3259B17
HMS3264F04
HSDB 7472
KB-272104
KS-1055
LS-186538
LS-187032
LS-187790
Lunesta
Lunesta (TN)
Lunivia
MFCD03700720
MLS001165744
NC00663
NCGC00159515-02
NCGC00159515-03
SAM002548982
SC-44982
SCHEMBL28657
SEP-0227018
SEP-0227108
SEP-190
SEP-225441
SMR000550478
SPECTRUM1505188
SR-05000001914
SR-05000001914-2
Tox21_111733
Tox21_111733_1
UNII-03A5ORL08Q component GBBSUAFBMRNDJC-INIZCTEOSA-N
UNII-UZX80K71OE
UZX80K71OE
VA10852
X-3655
ZINC19632834
Zopiclone S-enantiomer

US Patents and Regulatory Information for eszopiclone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd ESZOPICLONE eszopiclone TABLET;ORAL 208451-002 Sep 15, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wockhardt Ltd ESZOPICLONE eszopiclone TABLET;ORAL 091165-003 Jul 14, 2011 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wockhardt Ltd ESZOPICLONE eszopiclone TABLET;ORAL 091165-002 Jul 14, 2011 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lupin Ltd ESZOPICLONE eszopiclone TABLET;ORAL 091124-002 Sep 13, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for eszopiclone

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sunovion Pharms Inc LUNESTA eszopiclone TABLET;ORAL 021476-003 Dec 15, 2004 ➤ Sign Up ➤ Sign Up
Sunovion Pharms Inc LUNESTA eszopiclone TABLET;ORAL 021476-002 Dec 15, 2004 ➤ Sign Up ➤ Sign Up
Sunovion Pharms Inc LUNESTA eszopiclone TABLET;ORAL 021476-002 Dec 15, 2004 ➤ Sign Up ➤ Sign Up
Sunovion Pharms Inc LUNESTA eszopiclone TABLET;ORAL 021476-001 Dec 15, 2004 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Healthtrust
US Department of Justice
Harvard Business School
Cantor Fitzgerald
Federal Trade Commission
Teva
Fuji
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.